Abstract
This study was conducted to compare the clinical and microbiological characteristics of first and breakthrough neutropenic fever in hematologic malignancy patients after chemotherapy. Breakthrough neutropenic fever was any episode of fever, not present initially, that developed either during antibiotic therapy or within 1 week of discontinuation of therapy. A total of 687 neutropenic fever episodes in 241 patients were observed from April 2003 to March 2014. Blood cultures revealed 210 causative microorganisms: 199 (94.8%) were bacteria and 11 (5.2%) were fungi. Gram-negative bacteria predominated in both types of neutropenic episode (first 75% (120/160) vs. breakthrough 56% (18/32)) and the most common pathogen was Escherichia coli. Antibiotic resistance rates were higher in breakthrough episodes than first episodes (piperacillin/tazobactam 6% vs. 31%, p=0.006; ceftazidime 9% vs. 31%, p=0.025). Inappropriate empirical antibiotic treatment was also more frequent (0% vs. 19%, p=0.001), as was the 30-day mortality rate (4.3% (19/442) vs. 7.9% (19/245), p=0.058), although the latter effect was not statistically significant. It is concluded that the epidemiological profile of breakthrough neutropenic fever is different from that of...Continue Reading
References
Mar 1, 1990·The Journal of Infectious Diseases
Jan 1, 1985·Infection·P SerraP Martino
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M NucciW Pulcheri
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Murat AkovaUNKNOWN International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer
Oct 29, 2005·International Journal of Antimicrobial Agents·Huang Xiao JunJuan J Picazo
Nov 17, 2006·Journal of Medical Microbiology·Matthew E FalagasIoannis A Bliziotis
Jun 10, 2008·American Journal of Infection Control·Teresa C HoranMargaret A Dudeck
Aug 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Françoise Meunier, Colette Lukan
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Jul 1, 2011·The Korean Journal of Internal Medicine·Dong-Gun LeeJung-Hyun Choi
Jun 26, 2012·International Journal of Antimicrobial Agents·Ron RamMical Paul
Apr 29, 2015·Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology·Aslıhan DemirelRecep Öztürk
Citations
Jul 1, 2017·Expert Review of Anti-infective Therapy·Michail Alevizakos, Eleftherios Mylonakis
Feb 17, 2018·Infectious Diseases·Lenaïg Le ClechGaëlle Guillerm
Sep 19, 2017·Current Opinion in Infectious Diseases·Abby DouglasMonica Slavin